Showing results (361-370 of 524) with videos related to
Sort By:
Pageof 53
Thyroid : Official Journal of the American Thyroid Association|August 3, 2023
GlycA as a Novel Biomarker of Systemic Inflammation in HypothyroidismSarah Galvao, Isabela M Bensenor, Michael J Blaha, et al.Environmental Toxicology and Chemistry|November 9, 2001
Use of molecular markers to study the effects of environmental impacts on genetic diversity in brown bullhead (Ameirus nebulosus) populationsR N Silbiger, A C Leonard, P Dimsoski, et al.Diabetes, Obesity & Metabolism|June 12, 2018
Body mass index impacts the choice of lipid-lowering treatment with no correlation to blood cholesterol - Findings from 52 916 patients in the Dyslipidemia International Study (DYSIS)Jean Ferrières, Dominik Lautsch, Anselm K Gitt, et al.European Journal of Clinical Investigation|June 8, 2024
Phenotypes of Polish primary care patients using hierarchical clustering: Exploring the risk of mortality in the LIPIDOGEN2015 study cohortYang Chen, Ying Gue, Maciej Banach, et al.Clinical Nutrition (Edinburgh, Scotland)|September 19, 2019
Vitamin D supplementation and incident preeclampsia: A systematic review and meta-analysis of randomized clinical trialsSilvia Fogacci, Federica Fogacci, Maciej Banach, et al.International Journal of Cardiology|September 11, 2013
A meta-analysis of the role of statins on renal outcomes in patients with chronic kidney disease. Is the duration of therapy important?Dragana Nikolic, Maciej Banach, Shekoufeh Nikfar, et al.Journal of Clinical Lipidology|August 1, 2015
Low- and high-density lipoprotein subclasses in subjects with nonalcoholic fatty liver diseaseAlper Sonmez, Dragana Nikolic, Teoman Dogru, et al.Cephalalgia : an International Journal of Headache|May 11, 2017
The relationship between migraine and lipid sub-fractions among individuals without cardiovascular disease: A cross-sectional evaluation in the Brazilian Longitudinal Study of Adult Health (ELSA-Brasil)Alessandra C Goulart, Paulo A Lotufo, Itamar S Santos, et al.Kidney International|March 13, 2018
Efficacy and safety of lipid lowering by alirocumab in chronic kidney diseasePeter P Toth, Jamie P Dwyer, Christopher P Cannon, et al.Acta Neuropathologica|August 24, 2015
Rab1-dependent ER-Golgi transport dysfunction is a common pathogenic mechanism in SOD1, TDP-43 and FUS-associated ALSKai Y Soo, Mark Halloran, Vinod Sundaramoorthy, et al.Pageof 53